Chronic pain affects approximately 1 in 5 Canadians. For most, standard approaches — physical therapy, exercise, anti‑inflammatories, and first‑line oral medications — work reasonably well. For a smaller group, standard approaches don't provide enough relief, cause intolerable side effects, or aren't appropriate. This is the group for whom compounded pain medications are sometimes considered.

What Are Compounded Pain Medications?

Compounded pain medications are custom‑prepared formulations made from pharmaceutical‑grade ingredients. Common types include:

• Topical pain creams combining several active ingredients for localised relief.
• Low‑dose naltrexone (LDN) – naltrexone at 1.5–4.5 mg used off‑label for pain and inflammation.
• Custom‑strength oral medications for patients whose prescribed doses don't exist commercially.
• Combination capsules that bring several compatible pain medications into one dose.

Where Compounding Fits in the Treatment Hierarchy

Non‑Pharmacological Foundations

Physical therapy, graded exercise, cognitive behavioural therapy, sleep hygiene, stress management, and weight management are first‑line. Compounding works best when these are also addressed.

First‑Line Pharmacological Options

Standard analgesics, NSAIDs (oral/topical), gabapentinoids, SNRIs, and tricyclic antidepressants are evidence‑based for many pain types.

Where Compounding Is Considered

• First‑line options tried but inadequate or poorly tolerated.
• Side effects limit systemic medications.
• Pain is localised and may respond to topical delivery.
• Patient has sensitivities to commercial ingredients.
• Specific off‑label uses (e.g., LDN) where some evidence exists.

What Compounding Does Well

• Localised delivery – topical creams achieve high local concentration with low systemic absorption.
• Combinations not available commercially – multimodal creams addressing several pain mechanisms.
• Customisation for sensitivities – preservative‑free, dye‑free, gluten‑free.
• Precise dosing – for titration or unusual dose requirements.

Realistic Expectations

• Partial improvement (30–50% pain reduction) is common, not complete relief.
• Effects are gradual – often 4–12 weeks for LDN or consistent topical use.
• Not everyone responds; a meaningful fraction see no benefit.
• Best used as part of a multimodal plan, not as a standalone cure.

If you're considering compounded pain medications, start with a conversation with your prescriber. Useful questions: "What evidence supports this for my type of pain? What are realistic outcomes? How will we monitor response?"